Title:
METHOD FOR ACTIVATING SKIN STEM CELLS THROUGH MPC1 SUPPRESSION, AND SKIN STEM CELL ACTIVATION AGENT
Document Type and Number:
WIPO Patent Application WO/2021/125346
Kind Code:
A1
Abstract:
Provided are a method for activating skin stem cells, a skin stem cell activation agent, and a screening method for skin stem cell activation agents. The application of an MPC1 suppressant is effective in activating skin stem cells. Examples of such MPC1 suppressants include agents that include at least an akebia extract, a black bean extract, a peony extract, a tea extract, a jojoba leaf extract, or ergothioneine as an active ingredient. Moreover, skin stem cell activation agents can be screened using MPC1 suppression action as an index.
Inventors:
IRIYAMA SHUNSUKE (JP)
Application Number:
PCT/JP2020/047530
Publication Date:
June 24, 2021
Filing Date:
December 18, 2020
Export Citation:
Assignee:
SHISEIDO CO LTD (JP)
International Classes:
A61P43/00; A23L33/105; A61K8/9789; A61K31/4172; A61K36/185; A61K36/48; A61K36/65; A61P17/00; A61Q19/00; C12N5/0735; C12N5/074; C12N15/09; C12N15/12; C12Q1/02; C12Q1/6851; C12Q1/686; G01N33/15; G01N33/50
Foreign References:
| KR20170025365A | 2017-03-08 | |||
| US20150099790A1 | 2015-04-09 | |||
| JP2018123130A | 2018-08-09 | |||
| CN108392446A | 2018-08-14 |
Attorney, Agent or Firm:
AOKI, Atsushi et al. (JP)
Download PDF:
Previous Patent: VASODILATOR AND USE THEREOF
Next Patent: NOVEL COMPOUND, CROSSLINKING AGENT AND CROSSLINKED FLUOROELASTOMER
Next Patent: NOVEL COMPOUND, CROSSLINKING AGENT AND CROSSLINKED FLUOROELASTOMER